Explore more publications!
Health Times of Africa
Got News to Share?

Health Times of Africa: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Times of Africa.

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

Press releases published on January 15, 2026

60 Degrees Pharmaceuticals, Inc. Announces Approval of Reverse Stock Split Ratio
January 15, 2026

60 Degrees Pharmaceuticals, Inc. Announces Approval of Reverse Stock Split Ratio

Indeterminate GlobeNewswire
HMNC Brain Health Presented Positive Phase 2b Data at American College of Neuropsychopharmacology Annual Meeting
January 15, 2026

HMNC Brain Health Presented Positive Phase 2b Data at American College of Neuropsychopharmacology Annual Meeting

Indeterminate GlobeNewswire
ViroMissile Appoints Michael G. Wood as Chief Business Officer
January 15, 2026

ViroMissile Appoints Michael G. Wood as Chief Business Officer

Indeterminate GlobeNewswire
Collegium to Present Four Real-World Data Posters at APSARD 2026 Annual Conference
January 15, 2026

Collegium to Present Four Real-World Data Posters at APSARD 2026 Annual Conference

Indeterminate GlobeNewswire
American Oncology Research and MiBA Form Strategic Alliance to Integrate Real-Time Data Intelligence with Community-Based Clinical Research
January 15, 2026

American Oncology Research and MiBA Form Strategic Alliance to Integrate Real-Time Data Intelligence with Community-Based Clinical Research

Indeterminate GlobeNewswire
Extendicare Announces January 2026 Dividend of C$0.042 per Share
January 15, 2026

Extendicare Announces January 2026 Dividend of C$0.042 per Share

Indeterminate GlobeNewswire
Vaxart Publishes Positive Data for its Oral Bivalent Norovirus Candidate in Lactating Women and Their Infants
January 15, 2026

Vaxart Publishes Positive Data for its Oral Bivalent Norovirus Candidate in Lactating Women and Their Infants

Indeterminate GlobeNewswire
R1 Prior Authorization, Now Powered by the Phare OS, Accelerates Care, Reduces Costs and Improves Accuracy
January 15, 2026

R1 Prior Authorization, Now Powered by the Phare OS, Accelerates Care, Reduces Costs and Improves Accuracy

Indeterminate GlobeNewswire
Incannex Healthcare Wins Research and Development Award for Obstructive Sleep Apnea Program in the 2025 Clinical Trials Arena Excellence Awards
January 15, 2026

Incannex Healthcare Wins Research and Development Award for Obstructive Sleep Apnea Program in the 2025 Clinical Trials Arena Excellence Awards

Indeterminate GlobeNewswire
Cardiac Biotech Solutions Activates China Production Pipeline for MyCardia AT and Moves into Final NMPA Submission Phase
January 15, 2026

Cardiac Biotech Solutions Activates China Production Pipeline for MyCardia AT and Moves into Final NMPA Submission Phase

Indeterminate GlobeNewswire
Colorado, Montana, and Utah Among Nation’s Top States in RSV Protection for Babies Following Intermountain Health Awareness Effort
January 15, 2026

Colorado, Montana, and Utah Among Nation’s Top States in RSV Protection for Babies Following Intermountain Health Awareness Effort

Indeterminate GlobeNewswire
Medicenna Therapeutics Announces Key Program Updates and 2026 Outlook
January 15, 2026

Medicenna Therapeutics Announces Key Program Updates and 2026 Outlook

Indeterminate GlobeNewswire
Mount Sinai Becomes First in Metro New York to Deliver Incision-Free, MRI-Guided Prostate Treatment with TULSA-PRO®
January 15, 2026

Mount Sinai Becomes First in Metro New York to Deliver Incision-Free, MRI-Guided Prostate Treatment with TULSA-PRO®

Indeterminate GlobeNewswire
VapeAway® LLC Announces First Patient Enrolled in Clinical Study of Novel Vaping Cessation Device
January 15, 2026

VapeAway® LLC Announces First Patient Enrolled in Clinical Study of Novel Vaping Cessation Device

Indeterminate GlobeNewswire
AAVantgarde Completes Enrollment in LUCE-1 Phase 1/2 Clinical Trial of AAVB-081 for Usher Syndrome Type B-associated Retinitis Pigmentosa
January 15, 2026

AAVantgarde Completes Enrollment in LUCE-1 Phase 1/2 Clinical Trial of AAVB-081 for Usher Syndrome Type B-associated Retinitis Pigmentosa

Indeterminate GlobeNewswire
Axsome Therapeutics Initiates FORWARD Phase 3 Trial of AXS-14 for the Management of Fibromyalgia
January 15, 2026

Axsome Therapeutics Initiates FORWARD Phase 3 Trial of AXS-14 for the Management of Fibromyalgia

Indeterminate GlobeNewswire
Verano Announces Agreement to Upsize Revolving Credit Facility Commitment to $100,000,000 and Extend Maturity Date
January 15, 2026

Verano Announces Agreement to Upsize Revolving Credit Facility Commitment to $100,000,000 and Extend Maturity Date

Indeterminate GlobeNewswire
Abpro’s Lead Program ABP-102 Featured in Celltrion Presentation at the 44th Annual J.P. Morgan Healthcare Conference
January 15, 2026

Abpro’s Lead Program ABP-102 Featured in Celltrion Presentation at the 44th Annual J.P. Morgan Healthcare Conference

Indeterminate GlobeNewswire
Digbi Health Publishes Peer-Reviewed Data Demonstrating Significant Cost Savings for Employers Via Its Precision Biology Telehealth Platform to Manage GLP-1, Metabolic, and GI Costs
January 15, 2026

Digbi Health Publishes Peer-Reviewed Data Demonstrating Significant Cost Savings for Employers Via Its Precision Biology Telehealth Platform to Manage GLP-1, Metabolic, and GI Costs

Indeterminate GlobeNewswire
Verdane Invests in Clue to Accelerate the Future of Women’s Health
January 15, 2026

Verdane Invests in Clue to Accelerate the Future of Women’s Health

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions